Insights & Publications


New Areas of Discovery and Collaboration

Since its inception, TriCore’s Research Institute has experienced steady and continuous growth, emphasizing research in the field of infectious diseases. During the pandemic, the focus was on COVID Emergency Use Authorizations, which were crucial. The Institute is now diversifying to encompass more intricate studies, such as more complex COVID 510(k) submissions and other respiratory viruses….

Read More

TRI Partners with Sponsors for 510(k) Submissions

A 510(k) submission is a premarket submission made to the U.S. Food and Drug Administration (FDA) for the purpose of obtaining clearance to market a medical device or instrument in the United States. An in-vitro diagnostic (IVD) medical device manufacturer may need to submit a 510(k) application if it intends to introduce a new IVD…

Read More

TriCore Research Institute: A Reliable Partner in Innovation

In the dynamic landscape of medical research and technological advancements, TriCore Research Institute (TRI) has partnered with organizations to make scientific advances in medicine Infectious Disease Research Studies The year 2020 marked a watershed moment for TriCore Research Institute (TRI). The outbreak of the SARS-CoV-2 pandemic underscored the importance of agility and continuity in research…

Read More

Right Sample, Right Test, Right Remnant: The Remnant Equation

In the ever-evolving field of clinical research, the utilization of residual clinical samples has emerged as a valuable resource. These biological samples, which are collected during routine medical procedures, hold tremendous potential for advancing scientific knowledge and improving patient care. In this blog post, we will explore the significance of residual clinical samples and their…

Read More

TRI’s Biorepository Focus on Prospective Collection Services

We’ve switched more from the traditional biorepository of banked specimens to prospective specimen and consented collections services. These specimens have a richer data set and subject’s health record data associated with these biospecimens is much more valuable to researchers and scientists, as they not only have the lab results, but also relevant clinical information, such…

Read More